As of July 31, 2023, E-therapeutics Plc has 582.69M shares outstanding.
| Shares Outstanding | 582.69M |
As of July 31, 2023, E-therapeutics Plc maintains a current ratio of 22.20, meaning it holds 22.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 22.20 |
| Quick Ratio | 19.47 |
| Debt / Equity | 0.33 |
As of July 31, 2023, E-therapeutics Plc has an Altman Z-Score of -3.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -3.07 |
Already premium?